CYSTOGRAFIN DILUTE Rx
Generic Name and Formulations:
Diatrizoate meglumine 180mg/mL; soln for inj; contains organically bound iodine 85mg/mL.
Indications for CYSTOGRAFIN DILUTE:
Take laxative night before exam; low residue diet day before. Individualize. Fill bladder with 25–300mL depending on age of patient and degree of bladder irritability; >300mL may be used if bladder capacity allows.
Severe sensitivity reactions may occur; have emergency equipment available. Bronchial asthma. Significant allergies. Active UTI. Pregnancy (Cat.C).
May interfere with urine specimens.
Radiopaque contrast agent.
Hypersensitivity reactions, hypothyroidism.
Bottles (100mL, 300mL)—1; Dilute (300mL)—10
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- Can A Consortium of Hospitals Help To Reduce Drug Prices?
- NSCLC: Stratifying Patients With Complex EGFR Mutations
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC
- Everolimus Plus Letrozole: An Effective First-Line Therapy for Advanced Breast Cancer
- FDA Approves Nilotinib for Pediatric Patients With CML
- Nicotinamide and Cancer
- Nivolumab Plus Ipilimumab Improves Overall Survival, ORR in Renal Cell Carcinoma
- Encorafenib, Binimetinib May Be Effective in BRAF-Mutant Melanoma